Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Internal Medicine · BROOKLYN, NY · NPI 1134110547
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 653 | 200 |
| Lactulose | Lactulose | 316 | 40 |
| Gabapentin | Gabapentin | 287 | 74 |
| Eliquis | Apixaban | 251 | 40 |
| Metformin Hcl | Metformin Hcl | 251 | 81 |
| Losartan Potassium | Losartan Potassium | 241 | 73 |
| Prednisone | Prednisone | 241 | 155 |
| Nifedipine Er | Nifedipine | 223 | 63 |
| Meloxicam | Meloxicam | 210 | 90 |
| Latanoprost | Latanoprost | 204 | 26 |
| Atorvastatin Calcium | Atorvastatin Calcium | 193 | 69 |
| Levothyroxine Sodium | Levothyroxine Sodium | 187 | 47 |
| Levetiracetam | Levetiracetam | 179 | 22 |
| Montelukast Sodium | Montelukast Sodium | 166 | 53 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 163 | 54 |
| Carvedilol | Carvedilol | 158 | 48 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 152 | 53 |
| Tamsulosin Hcl | Tamsulosin Hcl | 121 | 44 |
| Mirtazapine | Mirtazapine | 118 | 28 |
| Quetiapine Fumarate | Quetiapine Fumarate | 117 | 29 |
| Azithromycin | Azithromycin | 113 | 89 |
| Furosemide | Furosemide | 105 | 32 |
| Metoprolol Succinate | Metoprolol Succinate | 105 | 38 |
| Metoprolol Tartrate | Metoprolol Tartrate | 100 | 23 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 99 | 20 |
| Donepezil Hcl | Donepezil Hcl | 89 | 18 |
| Famotidine | Famotidine | 88 | 27 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 82 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 81 | 13 |
| Divalproex Sodium | Divalproex Sodium | 75 | 18 |
| Simvastatin | Simvastatin | 73 | 24 |
| Baclofen | Baclofen | 71 | 15 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 66 | 26 |
| Memantine Hcl | Memantine Hcl | 65 | 16 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 65 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 64 | 22 |
| Lisinopril | Lisinopril | 62 | 20 |
| Levofloxacin | Levofloxacin | 60 | 51 |
| Omeprazole | Omeprazole | 60 | 24 |
| Doxycycline Hyclate | Doxycycline Hyclate | 59 | 47 |
| Fluticasone Propionate | Fluticasone Propionate | 59 | 39 |
| Januvia | Sitagliptin Phosphate | 57 | 13 |
| Risperidone | Risperidone | 57 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 55 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 54 | 14 |
| Labetalol Hcl | Labetalol Hcl | 52 | 18 |
| Pantoprazole Sodium | Pantoprazole Sodium | 52 | 17 |
| Glipizide Er | Glipizide | 50 | 15 |
| Zolpidem Tartrate | Zolpidem Tartrate | 49 | 17 |
| Finasteride | Finasteride | 48 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 47 | suppressed |
| Ibuprofen | Ibuprofen | 47 | 25 |
| Nystatin | Nystatin | 45 | 26 |
| Brimonidine Tartrate | Brimonidine Tartrate | 43 | suppressed |
| Glipizide | Glipizide | 43 | 16 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 43 | 13 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 42 | 26 |
| Enulose | Lactulose | 41 | 13 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 39 | 12 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 39 | 35 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 39 | suppressed |
| Ozempic | Semaglutide | 39 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 38 | 15 |
| Spironolactone | Spironolactone | 38 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 37 | 14 |
| Jardiance | Empagliflozin | 36 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 31 | 15 |
| Allopurinol | Allopurinol | 30 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 30 | 11 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 29 | suppressed |
| Novolog Flexpen | Insulin Aspart | 29 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 29 | suppressed |
| Potassium Chloride | Potassium Chloride | 29 | 12 |
| Tizanidine Hcl | Tizanidine Hcl | 29 | 11 |
| Mupirocin | Mupirocin | 28 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 28 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 28 | suppressed |
| Entresto | Sacubitril/Valsartan | 27 | 13 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 27 | suppressed |
| Entacapone | Entacapone | 26 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 26 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 25 | suppressed |
| Clonidine | Clonidine | 24 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 24 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 23 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 23 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 23 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 22 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 21 | 21 |
| Meclizine Hcl | Meclizine Hcl | 21 | suppressed |
| Scopolamine | Scopolamine | 21 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Bumetanide | Bumetanide | 20 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 20 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 20 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 18 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 18 | suppressed |
| Tetrabenazine | Tetrabenazine | 18 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 17 | 11 |
| Azelastine Hcl | Azelastine Hcl | 17 | suppressed |
| Clotrimazole | Clotrimazole | 17 | suppressed |
| Glimepiride | Glimepiride | 17 | suppressed |
| Olanzapine Odt | Olanzapine | 17 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 16 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 16 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 16 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 15 | suppressed |
| Pregabalin | Pregabalin | 15 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 14 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 14 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Nystop | Nystatin | 14 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 14 | suppressed |
| Rhopressa | Netarsudil Mesylate | 14 | suppressed |
| Valsartan | Valsartan | 14 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 13 | suppressed |
| Colchicine | Colchicine | 13 | suppressed |
| Fluconazole | Fluconazole | 13 | 12 |
| Phenytoin | Phenytoin | 13 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 13 | suppressed |
| Xarelto | Rivaroxaban | 13 | suppressed |
| Anastrozole | Anastrozole | 12 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 12 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 12 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 12 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 11 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 11 | suppressed |
| Fetroja | Cefiderocol Sulfate Tosylate | 11 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 11 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Telmisartan | Telmisartan | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error